Nuclear changes and p62 expression in ischemic and dilated cardiomyopathy;Cambios nucleares y expresión de p62 en la miocardiopatía isquémica y dilatada

Revista Espanola de Cardiologia

Volumn 60, Issue 12, 2007, Pages 1319-1323

  Cortés, Raquel ^a   Portolés Sanz, Manuel ^a   Roselló Lletí, Esther ^a   Martínez Dolz, Luis ^a   Almenar, Luis ^a   Salvador, Antonio ^a   Rivera, Miguel ^a  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cardiomyopathy; Heart failure; Proteins

Indexed keywords

PROTEIN P62;

ADULT; ARTICLE; CELL NUCLEUS; CLINICAL ARTICLE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; HETEROCHROMATIN; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; PROTEIN EXPRESSION; WESTERN BLOTTING;

EID: 37349132431     PISSN: 03008932     EISSN: 15792242     Source Type: Journal    
DOI: 10.1157/13113939     Document Type: Article

References (8)

1. Cohn JN, Ferrari R, Sharpe N. Cardiac remodeling-concepts and clinical implications: a consensus paper from an international forum on cardiac remodelling. J Am Coll Cardiol. 2000;35:569-82.
2. Fahrenkrog B. The nuclear pore complex, nuclear transport, and apoptosis. Can J Physiol Pharmacol. 2004;84:279-86.
3. Holt GD, Snow CM, Senior A, Haltiwanger RS, Gerace L. Nuclear pore complex glycoproteins contain cytoplasmically disposed O-linked N-acetylglucosamine. J Cell Biol. 1987;104:1157-64.
4. Perez-Terzic C, Behfar A, Mery A, Van Deursen JMA, Terzic A, Pucéat M. Structural adaptation of the nuclear pore complex in stem cell-derived cadiomyocytes. Cir Res. 2003;92:444-52.
5. Arrell K, Neverova I, Van Eyk JE. Cardiovascular proteomics. Evolution and potential. Circ Res. 2001;88:763-73.
6. Vivanco F, López-Bescós L, Tuñón J, Egido J. Proteómica y enfermedad cardiovascular. Rev Esp Cardiol. 2003;56:289-302.
7. Díez J, López B, González A, Ardanaz A, Fortuño MA. Respuestas del miocardio al estrés biomecánico. Rev Esp Cardiol. 2001;54:507-15.
8. Jessup M, Brozena S. Heart Failure. N Engl J Med. 2003;348:2007-18.